Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience
| Autor: | Sprakes, Michael B., Hamlin, P. John, Warren, Lisa, Greer, Dan, Ford, Alexander C. |
|---|---|
| Zdroj: | In Journal of Crohn's and Colitis 2011 5(4):324-331 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|